CD8(+)NKR-P1A(+) T cells preferentially accumulate in human liver
Citation
S. Ishihara et al., CD8(+)NKR-P1A(+) T cells preferentially accumulate in human liver, EUR J IMMUN, 29(8), 1999, pp. 2406-2413
Categorie Soggetti
Immunology
Journal title
EUROPEAN JOURNAL OF IMMUNOLOGY
SICI code
0014-2980(199908)29:8<2406:CTCPAI>2.0.ZU;2-E
Abstract
A unique subset of T cells that co-express NKR-P1, which is a lectin type o
f NK receptor and is thought to have a major role in triggering NK activity
, has been identified. In mice, NK1.1 (mouse NKR-P1C)(+) T cells, called NK
T cells, preferentially accumulate in the liver and bone marrow. They predo
minantly use invariant V alpha 14 chain VCR and phenotypically are CD4(+)CD
8(-) or CD4(-)CD8(-) T cells. In this study, we analyzed, phenotypically an
d functionally, the NKR-P1A (analogue of murine NKR-P1C)(+) T cells residen
t: in the human liver. Here, we show that in complete contrast to the NKT c
ells in the mouse liver, the majority of NKR-P1A(+) T cells in the human li
ver are CD8(+) and their TCR repertoire is not skewed to V alpha 24 TCR, th
e homologue of murine V alpha 14 TCR. Almost all of the NKR-P1A(+) T cells
in the human liver expressed CD69, suggesting that they were activated. Fur
thermore, the NKR-P1A(+) T cells in the human liver exhibited strong cytoto
xicity against a variety of tumor cell lines including K562, Molt4 and some
colonic adenocarcinoma cell lines.